Recent Finacing
Recent Raise
BioLeap is a drug discovery company using computational fragment-based drug design (CFBDD) to generate lead compounds and small-molecule scaffolds for disease-specific targets, partnering with pharma for early discovery.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors